Second transplantation after kidney graft loss in primary hyperoxaluria type 2: a pedigree study and mutation analysis.


Journal

Renal failure
ISSN: 1525-6049
Titre abrégé: Ren Fail
Pays: England
ID NLM: 8701128

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 24 10 2024
Statut: ppublish

Résumé

Primary hyperoxaluria type 2 (PH2) is a rare disorder caused by We report a case of PH2 with a three-generational pedigree. The The proband underwent her first kidney transplantation in 2015, and experienced recurrent urinary tract infections and urolithiasis postoperatively. Graft failure occurred in 2018. Whole exome sequencing identified compound heterozygous Our findings suggest that treatment strategies for the long-term prevention of oxalate nephropathy should be developed for patients with PH2 receiving isolated kidney transplantation. Moreover, the pathogenicity of the compound heterozygous

Sections du résumé

BACKGROUND UNASSIGNED
Primary hyperoxaluria type 2 (PH2) is a rare disorder caused by
METHODS UNASSIGNED
We report a case of PH2 with a three-generational pedigree. The
RESULTS UNASSIGNED
The proband underwent her first kidney transplantation in 2015, and experienced recurrent urinary tract infections and urolithiasis postoperatively. Graft failure occurred in 2018. Whole exome sequencing identified compound heterozygous
CONCLUSIONS UNASSIGNED
Our findings suggest that treatment strategies for the long-term prevention of oxalate nephropathy should be developed for patients with PH2 receiving isolated kidney transplantation. Moreover, the pathogenicity of the compound heterozygous

Identifiants

pubmed: 39444286
doi: 10.1080/0886022X.2024.2417743
doi:

Substances chimiques

Alcohol Oxidoreductases EC 1.1.-
glyoxylate reductase EC 1.1.1.26

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

2417743

Auteurs

Yushi Peng (Y)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Yingchun Zheng (Y)

Department of Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

Fu Xiong (F)

Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

Mingming Zhang (M)

Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

Yuchen Wang (Y)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Jia Luo (J)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Wenli Zeng (W)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Jialiang Hui (J)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Wenfeng Deng (W)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Jian Xu (J)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Yun Miao (Y)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Renfei Xia (R)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Yiling Fang (Y)

Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH